News
Analysis
Investments
Funds
PA Plus
Events
Magazines

News
Analysis
Investments
Funds
PA Plus
Events
Magazines

Coronavirus weekly round-up: Gilead drug trial excites markets but US growth falls 4.8%

Five investors mull the events shaping portfolios over the past week

Search portfolio Adviser

Sponsored by iShares

Ready to rethink your portfolio? Putting cash to work with bond ETFs

01 May 2020

|

Jessica Tasman-Jones

MORE ARTICLES ON

biotech , Coronavirus, coronavirus weekly round-up

Latest Stories

FCA proposes extending investment research rules to pooled funds

Regulator wants to widen scope of recent research rule overhaul to UCITS and alternative investment funds

November 5, 2024
Square Mile removes Jupiter Global Value rating on Whitmore exit

While three strategies entered the Square Mile Academy of Funds in October

November 5, 2024
Track to the Future – with William Blair’s Tom Ross

How fund group distribution bosses are thinking about asset classes, strategies and working with clients over the next 12 months

November 5, 2024
Schroders’ AUM reaches new high but net outflows fall by £2.3bn

Group warned of Q4 £8bn outflow from legacy Scottish Widows mandate

November 5, 2024
Weiss Korea Opportunity to undergo strategic review

Investment manager says the trust’s opportunity set is ‘less attractive’ than it has been in the past

November 4, 2024
Calastone: Equity funds suffer worst outflows on record

Bonds balloon by £631m while money markets increase £402m

November 4, 2024

About Us
Cookie policy
Privacy policy
Acceptable use policy
Terms and conditions
Contact

LinkedIn

Published by MA Financial Media Ltd (part of Mark Allen),
St Jude’s Church, London SE24 0PB . Copyright (c) 2024.

Portfolio Adviser is a monthly news magazine and daily news web site aimed at wealth managers , investment IFAs and other professional fund pickers and asset allocators in the UK and Channel Islands. No news, articles or content may be reproduced in part or in full without express permission of Portfolio Adviser.